MS18.02 Circulating Nucleic Acid Biomarkers

Encouraging results in lung cancer (LC) mortality reduction were obtained by the introduction of low dose computed tomography (LDCT) for lung cancer screening. The results of Nelson screening trial showed a 26% reduction in lung cancer mortality in the LDCT arm thus confirming the benefit of LC screening with LDCT already published by the NLST group (1). In MILD trial we showed that at 10 years follow up the mortality reduction was even higher...